These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19874646)

  • 1. Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.
    Fang WB; Chang Y; McCance-Katz EF; Moody DE
    J Anal Toxicol; 2009 Oct; 33(8):409-17. PubMed ID: 19874646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
    Fang WB; Lofwall MR; Walsh SL; Moody DE
    J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
    Moody DE; Slawson MH; Strain EC; Laycock JD; Spanbauer AC; Foltz RL
    Anal Biochem; 2002 Jul; 306(1):31-9. PubMed ID: 12069411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
    Moody DE; Laycock JD; Spanbauer AC; Crouch DJ; Foltz RL; Josephs JL; Amass L; Bickel WK
    J Anal Toxicol; 1997 Oct; 21(6):406-14. PubMed ID: 9323518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
    Neuvonen M; Neuvonen PJ
    Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry.
    Partani P; Modhave Y; Gurule S; Khuroo A; Monif T
    J Pharm Biomed Anal; 2009 Dec; 50(5):966-76. PubMed ID: 19640669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry.
    Swortwood MJ; Scheidweiler KB; Barnes AJ; Jansson LM; Huestis MA
    J Chromatogr A; 2016 May; 1446():70-7. PubMed ID: 27083254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism.
    Lin SN; Chang Y; Moody DE; Foltz RL
    J Anal Toxicol; 2004 Sep; 28(6):443-8. PubMed ID: 15516294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits.
    Slawson MH; Chen M; Moody D; Comer SD; Nuwayser ES; Fang WB; Foltz RL
    J Anal Toxicol; 2007 Oct; 31(8):453-61. PubMed ID: 17988459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions.
    Leuppi-Taegtmeyer A; Duthaler U; Hammann F; Schmid Y; Dickenmann M; Amico P; Jehle AW; Kalbermatter S; Lenherr C; Meyer Zu Schwabedissen HE; Haschke M; Liechti ME; Krähenbühl S
    Nephrol Dial Transplant; 2019 Apr; 34(4):692-702. PubMed ID: 30189012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
    Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
    Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples.
    Favretto D; Frison G; Vogliardi S; Ferrara SD
    Rapid Commun Mass Spectrom; 2006; 20(8):1257-65. PubMed ID: 16550495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
    Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
    Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of buprenorphine, naloxone and their metabolites in rat plasma using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry.
    Joshi A; Parris B; Liu Y; Heidbreder C; Gerk PM; Halquist M
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality Assessment of Expired Naloxone Products from First-Responders' Supplies.
    Pruyn S; Frey J; Baker B; Brodeur M; Graichen C; Long H; Zheng H; Dailey MW
    Prehosp Emerg Care; 2019; 23(5):647-653. PubMed ID: 30596290
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Fang WB; Andrenyak DM; Moody DE; Nuwayser ES
    J Anal Toxicol; 2005 Apr; 29(3):169-74. PubMed ID: 15842759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
    Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
    Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma.
    Sun W; Qu S; Du Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():157-63. PubMed ID: 24566267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment.
    Douglas Bruce R; Moody DE; Chodkowski D; Andrews L; Fang WB; Morrison J; Parsons TL; Friedland GH
    Am J Drug Alcohol Abuse; 2013 Mar; 39(2):80-5. PubMed ID: 23421567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.